carnosine has been researched along with fluorouracil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, K; Nagai, K; Suda, T; Yamaguchi, Y | 1 |
| Araki, H; Cui, R; Li, B; Mitsuhashi, H; Suemaru, K | 1 |
| Fujiki, Y; Hama, T; Hatake, K; Ishibashi, M; Kawakami, K; Kawata, K; Mishima, Y; Nemoto, M; Sugisaki, T; Takahashi, S; Yokoyama, M | 1 |
| Bevilacqua, MA; Guardia, F; Iovine, B; Irace, C | 1 |
| Li, M; Liang, X; Liu, Z; Teng, N; Wang, X; Xie, W; Yang, Z; Zhang, Z | 1 |
| El Abhar, H; Saad, AS; Saleh, S; Schaalan, M; Yehia, R | 1 |
2 trial(s) available for carnosine and fluorouracil
| Article | Year |
|---|---|
[Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer].
Topics: Adult; Aged; Alginates; Antineoplastic Combined Chemotherapy Protocols; Carnosine; Cisplatin; Docetaxel; Dosage Forms; Female; Fluorouracil; Glucuronic Acid; Head and Neck Neoplasms; Hexuronic Acids; Humans; Male; Middle Aged; Organometallic Compounds; Solutions; Stomatitis; Taxoids; Zinc Compounds | 2011 |
L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carnosine; Caspase 3; Colorectal Neoplasms; Egypt; Female; Fluorouracil; Humans; Leucovorin; Male; Malondialdehyde; Middle Aged; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Peripheral Nerves; Peripheral Nervous System Diseases; Pilot Projects; Prospective Studies; Signal Transduction; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
4 other study(ies) available for carnosine and fluorouracil
| Article | Year |
|---|---|
[Effects of L-carnosine on blood cells and biomembrane].
Topics: Animals; Blood Cell Count; Carnosine; Cell Membrane; Erythrocytes; Fluorouracil; Leukocytes; Lysosomes; Male; Mitomycin; Mitomycins; Phenylhydrazines; Rats; Rats, Inbred Strains; Zidovudine | 1990 |
Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in hamsters.
Topics: Administration, Topical; Alginates; Analysis of Variance; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Area Under Curve; Azulenes; Body Weight; Carnosine; Cricetinae; Dexamethasone; Drug Carriers; Drug Evaluation, Preclinical; Fluorouracil; Glucuronic Acid; Hexuronic Acids; Mesocricetus; Oral Ulcer; Organometallic Compounds; Stomatitis; Time Factors; Zinc Compounds | 2006 |
l-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; bcl-2-Associated X Protein; Carnosine; Cell Proliferation; Cell Survival; Colonic Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; HSP27 Heat-Shock Proteins; HT29 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Proto-Oncogene Proteins c-bcl-2 | 2016 |
Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Topics: Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Carnosine; Cell Proliferation; Colorectal Neoplasms; Diarrhea; Drug Interactions; Fluorouracil; Intestinal Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mucositis; Organometallic Compounds; Weight Loss; Xenograft Model Antitumor Assays; Zinc Compounds | 2017 |